$201.72
-0.74[-0.37%]
At close: Apr 25
$201.72
0[0.00%]
PreMarket: 5:19PM EDT
Biogen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Biogen using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
07/23/2024 | AM | BIIB | Q2 | $4.02 | — | — | — | $2.46B | — | — | — | Get Alert |
04/24/2024 | AM | BIIB | Q1 | $3.40 | $3.44 | $3.67 | 6.69% | $2.46B | $2.31B | $2.29B | -0.82% | Get Alert |
02/13/2024 | AM | BIIB | Q4 | $4.05 | $3.18 | $2.95 | -7.23% | $2.54B | $2.46B | $2.39B | -3.20% | Get Alert |
11/08/2023 | AM | BIIB | Q3 | $4.77 | $3.99 | $4.36 | 9.27% | $2.51B | $2.39B | $2.53B | 5.86% | Get Alert |
07/25/2023 | AM | BIIB | Q2 | $5.25 | $3.77 | $4.02 | 6.63% | $2.59B | $2.37B | $2.46B | 3.63% | Get Alert |
04/25/2023 | AM | BIIB | Q1 | $3.62 | $3.28 | $3.40 | 3.66% | $2.53B | $2.34B | $2.46B | 5.26% | Get Alert |
02/15/2023 | AM | BIIB | Q4 | $3.39 | $3.48 | $4.05 | 16.38% | $2.73B | $2.44B | $2.54B | 4.26% | Get Alert |
10/25/2022 | AM | BIIB | Q3 | $4.77 | $4.16 | $4.77 | 14.66% | $2.78B | $2.47B | $2.51B | 1.56% | Get Alert |
07/20/2022 | AM | BIIB | Q2 | $5.68 | $4.10 | $5.25 | 28.05% | $2.77B | $2.48B | $2.59B | 4.40% | Get Alert |
05/03/2022 | AM | BIIB | Q1 | $5.34 | $4.38 | $3.62 | -17.35% | $2.69B | $2.49B | $2.53B | 1.69% | Get Alert |
02/03/2022 | AM | BIIB | Q4 | $4.58 | $3.40 | $3.39 | -0.29% | $2.85B | $2.62B | $2.73B | 4.35% | Get Alert |
10/20/2021 | AM | BIIB | Q3 | $8.84 | $4.11 | $4.77 | 16.06% | $3.38B | $2.67B | $2.78B | 4.08% | Get Alert |
07/22/2021 | AM | BIIB | Q2 | $10.26 | $4.55 | $5.68 | 24.84% | $3.68B | $2.61B | $2.77B | 6.32% | Get Alert |
04/22/2021 | AM | BIIB | Q1 | $9.14 | $5.04 | $5.34 | 5.95% | $3.53B | $2.65B | $2.69B | 1.66% | Get Alert |
02/03/2021 | AM | BIIB | Q4 | $8.34 | $4.87 | $4.58 | -5.95% | $3.67B | $2.80B | $2.85B | 1.88% | Get Alert |
10/21/2020 | AM | BIIB | Q3 | $9.17 | $8.13 | $8.84 | 8.73% | $3.60B | $3.35B | $3.38B | 0.78% | Get Alert |
07/22/2020 | AM | BIIB | Q2 | $9.15 | $8.04 | $10.26 | 27.61% | $3.62B | $3.44B | $3.68B | 7.03% | Get Alert |
04/22/2020 | AM | BIIB | Q1 | $6.98 | $7.74 | $9.14 | 18.09% | $3.49B | $3.41B | $3.53B | 3.64% | Get Alert |
01/30/2020 | AM | BIIB | Q4 | $6.99 | $7.92 | $8.34 | 5.30% | $3.53B | $3.52B | $3.67B | 4.29% | Get Alert |
Biogen (BIIB) is scheduled to report earnings on July 23, 2024. The last reported earnings were for reported on April 24, 2024 for Q1.
The Actual EPS was $3.67, which beat the estimate of $3.44.
The Actual Revenue was $2.3B, which missed the estimate of $2.3B.
Browse earnings estimates, EPS, and revenue on all stocks.